Form 990 for tax year 2024
Filed by CHILDRENS CANCER THERAPY DEVELOPMENT INSTITUTE.
Totals
- Total revenue
- $2,370,110
- Total expenses
- $2,699,549
- Contributions and grants received
- $2,424,760
- Grants paid
- $0
- Program service revenue
- $0
- Investment income
- -$54,650
- Other revenue
- $0
- Total assets, end of year
- $2,777,007
- Total liabilities, end of year
- $639,604
- Net assets or fund balances, end of year
- $2,137,403
- Program services expenses (Part IX)
- $2,064,850
- Management and general expenses
- $405,862
- Fundraising expenses
- $228,837
- Program service expenses (Part III)
- $2,064,850
Program services were 76.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1e · Government grants (contributions)
$261,095
-
1f · All other contributions, gifts and grants
$2,163,665
-
1g · Noncash contributions included above
$146,705
-
2a · Program service revenue: OTHER INCOME
-
2b · Program service revenue: PROGRAM REVENUE
-
3 · Investment income
total $21,081 · excluded $21,081
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $0
-
6d · Net rental income or loss
total $0
-
7b · Less cost or other basis and sales expenses
other assets $75,731
-
7c · Gain or loss
other assets -$75,731
-
7d · Net gain or loss
total -$75,731 · related or exempt -$75,731
-
8c · Net income from fundraising events
total $0
-
9c · Net income from gaming
total $0
-
10c · Net income from sales of inventory
total $0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $0
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $0
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $427,003 · program services $226,808 · management and general $200,195
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $636,331 · program services $480,959 · management and general $48,192 · fundraising $107,180
-
8 · Pension plan contributions
total $38,776 · program services $25,810 · management and general $9,058 · fundraising $3,908
-
9 · Other employee benefits
total $30,914 · program services $20,577 · management and general $7,221 · fundraising $3,116
-
10 · Payroll taxes
total $84,427 · program services $56,196 · management and general $19,721 · fundraising $8,510
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $0
-
11c · Fees: accounting
total $0
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $0
-
11f · Fees: investment management
total $0
-
11g · Fees: other
total $343,401 · program services $198,642 · management and general $80,404 · fundraising $64,355
-
12 · Advertising and promotion
total $0
-
13 · Office expenses
total $16,381 · program services $8,639 · management and general $1,616 · fundraising $6,126
-
14 · Information technology
total $404,125 · program services $394,418 · management and general $2,622 · fundraising $7,085
-
15 · Royalties
total $0
-
16 · Occupancy
total $248,058 · program services $195,648 · management and general $33,514 · fundraising $18,896
-
17 · Travel
total $35,460 · program services $35,081 · management and general $60 · fundraising $319
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $0
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $360,474 · program services $360,474
-
23 · Insurance
total $9,506 · program services $7,929 · management and general $1,577
-
24a · Other expenses: ARTISAN BIOPHARMA LLC EXPENSES
total $23,681 · program services $23,681
-
24b · Other expenses: MARKETING AND COMMUNICATIONS
total $21,806 · program services $19,520 · management and general $390 · fundraising $1,896
-
24c · Other expenses: LICENSES, DUES & FEES
total $15,878 · program services $9,825 · management and general $1,292 · fundraising $4,761
-
24d · Other expenses: MISCELLANEOUS
total $3,328 · program services $643 · fundraising $2,685
-
24e · All other expenses
total $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $71,040 · end of year $335,106
-
2 · Savings and temporary cash investments
beginning of year $422,169 · end of year $114,396
-
3 · Pledges and grants receivable
beginning of year $373,229 · end of year $348,494
-
4 · Accounts receivable
end of year $0
-
5 · Loans and receivables from officers and key people
end of year $0
-
6 · Loans and receivables from disqualified persons
end of year $0
-
7 · Other notes and loans receivable
end of year $0
-
8 · Inventories for sale or use
end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $129,612 · end of year $105,525
-
10a · Land, buildings and equipment: cost or other basis
$2,473,913
-
10b · Land, buildings and equipment: accumulated depreciation
$1,153,363
-
10c · Land, buildings and equipment, net
beginning of year $1,590,875 · end of year $1,320,550
-
11 · Investments: publicly traded securities
end of year $0
-
12 · Investments: other securities
end of year $0
-
13 · Investments: program-related
beginning of year $75,731 · end of year $0
-
14 · Intangible assets
end of year $0
-
15 · Other assets
beginning of year $677,360 · end of year $552,936
-
17 · Accounts payable and accrued expenses
beginning of year $182,082 · end of year $66,863
-
25 · Other liabilities
beginning of year $691,092 · end of year $572,741
-
27 · Net assets without donor restrictions
beginning of year $1,955,645 · end of year $1,625,136
-
28 · Net assets with donor restrictions
beginning of year $511,197 · end of year $512,267
Mission and programs · 2024
Mission
TO MAKE ALL CHILDHOOD CANCERS UNIVERSALLY SURVIVABLE BY DELIVERING NEW TREATMENTS TO CLINICAL TRIALS THROUGH SCIENTIFIC DISCOVERY.
-
RESEARCHOUR CURRENT PRIMARY FOCUS AREAS ARE RHABDOMYOSARCOMA, NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMES (NRSTS) INCLUDING EPITHELIOID SARCOMA, DIFFUSE INTRINSIC PONTINE GLIOMA, PEDIATRIC HIGH GRADE GLIOMA, HEPATOBLASTOMA, OSTEOSARCOMA, CLEAR CELL SARCOMA/EWING'S SARCOMA, WILMS' TUMOR, AND MEDULLOBLASTOMA. WE ADDRESS PEDIATRIC CANCERS THAT OCCUR ACROSS ALL AGE RANGES FROM CHILDREN TO ADOLESCENTS, YOUNG ADULTS AND OLDER ADULTS.
Expenses $2,064,850
As filed on the 2024 return.
Listed in Part VII
-
Charles KellerCHARLES KELLER
Science Dir.
- Total calculated
- $345,572
- From this org
- $313,114
- From related orgs
- $0
- Other
- $32,458
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $313,114
- Bonus
- not reported
- Other
- not reported
- Deferred
- $26,323
- Nontaxable benefits
- $6,135
- Filer's total
- $345,572
-
Claire NewmanCLAIRE NEWMAN
Executive Dir.
- Total calculated
- $78,067
- From this org
- $74,194
- From related orgs
- $0
- Other
- $3,873
- Hours/week
- 40
-
John GrantJOHN GRANT
Board Chair
- Total calculated
- $0
- Hours/week
- 0.5
-
Paul MetzgarPAUL METZGAR
Co-Treasurer
- Total calculated
- $0
- Hours/week
- 0.5
-
David DiltsDAVID DILTS
Co-Treasurer
- Total calculated
- $0
- Hours/week
- 0.5
-
Jason McGillJASON MCGILL
Co-Treasurer
- Total calculated
- $0
- Hours/week
- 0.5
-
Gary NagamoriGARY NAGAMORI
Compliance Off.
- Total calculated
- $0
- Hours/week
- 0.5
-
Michelle MetzgarMICHELLE METZGAR
Chair Elect
- Total calculated
- $0
- Hours/week
- 0.5
-
Michael LinMICHAEL LIN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
-
Levi SeedLEVI SEED
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
-
Lisa HowardLISA HOWARD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
-
Kenya RobertsonKENYA ROBERTSON
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
-
Chris RasmussenCHRIS RASMUSSEN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
-
Tina Richards-LynnTINA RICHARDS-LYNN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
-
Tonia RogersTONIA ROGERS
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Disregarded entities
Part I: entities that legally are the filer and file no return of their own.
-
ARTISAN BIOPHARMA LLC
CANCER RESEARCH · OR · income -$23,681 · assets $33,127
Directly controlled by CHILDRENS CANCER THERAPY DEV INST
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
ARTISAN BIOPHARMA INC
C CORP · CANCER RESEARCH · OR · 100% owned · controlled entity
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 9 December 2025
- IRS schema version
- 2024v5.2
- Source object
- 202513439349300541
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.